A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

NCT06108219 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Steatohepatitis (NASH)
Metabolic Dysfunction-associated Steatohepatitis (MASH)

Interventions

DRUG: Miricorilant (Cohort A)
DRUG: Placebo (Cohort A)
DRUG: Miricorilant (Cohort B)
DRUG: Placebo (Cohort B)

Sponsor

Corcept Therapeutics